20-044
Showing 1 - 25 of >10,000
Obesity, Diabetes, Type 2 Trial in Worldwide (Semaglutide, Placebo)
Recruiting
- Obesity
- Diabetes Mellitus, Type 2
- Semaglutide
- Placebo
-
Birmingham, Alabama
- +73 more
Jan 24, 2023
Meningococcal B Disease Trial in Worldwide (rLP2086 vaccine, Pediatric HAV vaccine)
Completed
- Meningococcal B Disease
- rLP2086 vaccine
- Pediatric HAV vaccine
-
Canberra, Garran, Australian Capital Territory, Australia
- +24 more
Aug 30, 2021
Asthma Trial in Worldwide (MEDI3506, Placebo)
Active, not recruiting
- Asthma
- MEDI3506
- Placebo
-
Bakersfield, California
- +64 more
Dec 19, 2022
Non Cystic Fibrosis Bronchiectasis Trial in Worldwide (Colistimethate sodium, Saline Solution)
Completed
- Non Cystic Fibrosis Bronchiectasis
- Colistimethate sodium
- Saline Solution
-
Newport Beach, California
- +88 more
May 31, 2022
Type 2 Diabetes Trial in Worldwide (LY3209590, Insulin Degludec)
Active, not recruiting
- Type 2 Diabetes
- LY3209590
- Insulin Degludec
-
Little Rock, Arkansas
- +129 more
Jan 19, 2023
Heart Failure, Heart Failure With Preserved Ejection Fraction Trial in Worldwide (LY3540378, Placebo)
Not yet recruiting
- Heart Failure
- Heart Failure With Preserved Ejection Fraction
- LY3540378
- Placebo
-
Tucson, Arizona
- +89 more
Nov 14, 2022
Asthma Trial in Worldwide (Tezepelumab)
Recruiting
- Asthma
- Tezepelumab
-
Newport Beach, California
- +102 more
Jan 11, 2023
Coronavirus Disease 2019 Previously Enrolled inRO7496998 Study
Completed
- COVID-19
- Long COVID
-
Mar Del Plata, Argentina
- +44 more
Apr 15, 2022
Advanced or Metastatic Solid Tumor Malignancies Trial in United States (NP-G2-044 Monotherapy, Anti-PD-(L)1 Therapy, NP-G2-044
Recruiting
- Advanced or Metastatic Solid Tumor Malignancies
- NP-G2-044 Monotherapy
- +2 more
-
Scottsdale, Arizona
- +14 more
Jan 5, 2023
COPD (COPD) Trial in Worldwide (Tozorakimab, Placebo)
Not yet recruiting
- Chronic Obstructive Pulmonary Disease (COPD)
- Tozorakimab
- Placebo
-
Lincoln, California
- +113 more
Feb 15, 2023
Chronic Lymphocytic Leukemia (CLL) Trial in United States (Obinutuzumab, Venetoclax)
Recruiting
- Chronic Lymphocytic Leukemia (CLL)
-
Basking Ridge, New Jersey
- +6 more
Jan 3, 2023
Diabetes, Type 2 Trial in Worldwide (vildagliptin + metformin, metformin)
Completed
- Diabetes Mellitus, Type 2
- vildagliptin + metformin
- metformin
-
Pine Bluff, Arkansas
- +62 more
Dec 11, 2020
Acute Postoperative Pain, Bunionectomy Trial in United States (ACP-044 Dose A, ACP-044 Dose B, Placebo)
Completed
- Acute Postoperative Pain
- Bunionectomy
- ACP-044 Dose A
- +2 more
-
Anaheim, California
- +3 more
May 5, 2022
Diabetes, Type 2 Trial in Worldwide (Semaglutide, Placebo (semaglutide))
Completed
- Diabetes Mellitus, Type 2
- Semaglutide
- Placebo (semaglutide)
-
Birmingham, Alabama
- +128 more
Feb 14, 2022
Nasal Polyps, Chronic Rhinosinusitis Trial in Worldwide (Omalizumab, Placebo)
Completed
- Nasal Polyps
- Chronic Rhinosinusitis
- Omalizumab
- Placebo
-
Birmingham, Alabama
- +78 more
Mar 31, 2022
Refractory and/or Unexplained Chronic Cough Trial in Worldwide (BAY1817080, Placebo)
Completed
- Refractory and/or Unexplained Chronic Cough
- BAY1817080
- Placebo
-
Los Angeles, California
- +98 more
Jul 24, 2022
Pulmonary Disease, Chronic Obstructive Trial in Poland, Russian Federation, United States (FF/UMEC/VI, Tiotropium,
Completed
- Pulmonary Disease, Chronic Obstructive
- FF/UMEC/VI
- +7 more
-
Andalusia, Alabama
- +71 more
Jul 13, 2021
Type 2 Diabetes Trial in Worldwide (Tirzepatide, Insulin Glargine)
Completed
- Type 2 Diabetes Mellitus
- Tirzepatide
- Insulin Glargine
-
Anaheim, California
- +215 more
Jan 21, 2022